Tag: NeuroRelease

InVivo Therapeutics clashes with PixarBio over proposed takeover

Invivo Therapeutics has rebuked a press release from PixarBio claiming that it had made a US$77,000,000 stock offer to acquire the company. The colourfully-worded release,...

PixarBio establishes research centre focusing on spinal cord injury treatment

PixarBio—developers of NeuroRelease, a morphine replacement, non-opioid pain treatment—has established the JP Reynolds Research Center in Woburn, USA. The lab will focus on research and...